Monetary Management Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $887K | Sell |
1,770
-100
| -5% | -$48K | 0.18% | 105 |
|
|
2026
Q1 | $919K | Sell |
1,870
-935
| -33% | -$507K | 0.22% | 99 |
|
|
2025
Q4 | $1.63M | Hold |
2,805
| – | – | 0.38% | 58 |
|
|
2025
Q3 | $1.36M | Hold |
2,805
| – | – | 0.31% | 68 |
|
|
2025
Q2 | $1.14M | Hold |
2,805
| – | – | 0.28% | 79 |
|
|
2025
Q1 | $1.4M | Buy |
2,805
+10
| +0.4% | +$5.42K | 0.38% | 61 |
|
|
2024
Q4 | $1.45M | Hold |
2,795
| – | – | 0.38% | 61 |
|
|
2024
Q3 | $1.73M | Sell |
2,795
-1,010
| -27% | -$598K | 0.44% | 48 |
|
|
2024
Q2 | $2.1M | Sell |
3,805
-620
| -14% | -$355K | 0.56% | 39 |
|
|
2024
Q1 | $2.57M | Hold |
4,425
| – | – | 0.72% | 32 |
|
|
2023
Q4 | $2.35M | Sell |
4,425
-657
| -13% | -$318K | 0.73% | 30 |
|
|
2023
Q3 | $2.57M | Sell |
5,082
-80
| -2% | -$42.6K | 0.86% | 27 |
|
|
2023
Q2 | $2.69M | Sell |
5,162
-1,400
| -21% | -$755K | 0.83% | 30 |
|
|
2023
Q1 | $3.78M | Hold |
6,562
| – | – | 1.11% | 18 |
|
|
2022
Q4 | $3.61M | Hold |
6,562
| – | – | 1.13% | 19 |
|
|
2022
Q3 | $3.33M | Sell |
6,562
-25
| -0.4% | -$14K | 1.1% | 18 |
|
|
2022
Q2 | $3.58M | Sell |
6,587
-1,180
| -15% | -$649K | 1.12% | 18 |
|
|
2022
Q1 | $4.59M | Sell |
7,767
-25
| -0.3% | -$14.4K | 1.22% | 16 |
|
|
2021
Q4 | $5.2M | Sell |
7,792
-183
| -2% | -$114K | 1.29% | 16 |
|
|
2021
Q3 | $4.56M | Buy |
7,975
+215
| +3% | +$118K | 1.25% | 17 |
|
|
2021
Q2 | $3.92M | Sell |
7,760
-405
| -5% | -$191K | 1.18% | 19 |
|
|
2021
Q1 | $3.73M | Sell |
8,165
-600
| -7% | -$286K | 1.17% | 16 |
|
|
2020
Q4 | $4.08M | Buy |
8,765
+15
| +0.2% | +$7.03K | 1.35% | 15 |
|
|
2020
Q3 | $3.86M | Sell |
8,750
-790
| -8% | -$326K | 1.38% | 16 |
|
|
2020
Q2 | $3.46M | Sell |
9,540
-1,500
| -14% | -$503K | 1.31% | 14 |
|
|
2020
Q1 | $3.13M | Sell |
11,040
-375
| -3% | -$118K | 1.39% | 16 |
|
|
2019
Q4 | $3.71M | Sell |
11,415
-2,975
| -21% | -$902K | 1.36% | 15 |
|
|
2019
Q3 | $4.19M | Sell |
14,390
-1,735
| -11% | -$497K | 1.59% | 11 |
|
|
2019
Q2 | $4.74M | Sell |
16,125
-100
| -0.6% | -$27.5K | 1.82% | 8 |
|
|
2019
Q1 | $4.44M | Sell |
16,225
-100
| -0.6% | -$24.9K | 1.76% | 11 |
|
|
2018
Q4 | $3.65M | Sell |
16,325
-200
| -1% | -$46.9K | 1.65% | 13 |
|
|
2018
Q3 | $4.03M | Sell |
16,525
-275
| -2% | -$63.3K | 1.54% | 15 |
|
|
2018
Q2 | $3.48M | Hold |
16,800
| – | – | 1.42% | 20 |
|
|
2018
Q1 | $3.47M | Buy |
16,800
+785
| +5% | +$165K | 1.44% | 21 |
|
|
2017
Q4 | $3.04M | Buy |
16,015
+3,365
| +27% | +$645K | 1.23% | 27 |
|
|
2017
Q3 | $2.39M | Buy |
12,650
+500
| +4% | +$90.6K | 1.01% | 33 |
|
|
2017
Q2 | $2.12M | Buy |
12,150
+75
| +0.6% | +$12.6K | 0.87% | 37 |
|
|
2017
Q1 | $1.85M | Buy |
12,075
+450
| +4% | +$68.8K | 0.81% | 43 |
|
|
2016
Q4 | $1.64M | Sell |
11,625
-5,500
| -32% | -$811K | 0.76% | 47 |
|
|
2016
Q3 | $2.72M | Sell |
17,125
-575
| -3% | -$88.6K | 1.26% | 28 |
|
|
2016
Q2 | $2.62M | Hold |
17,700
| – | – | 1.22% | 29 |
|
|
2016
Q1 | $2.51M | Buy |
17,700
+150
| +0.9% | +$20.1K | 1.22% | 26 |
|
|
2015
Q4 | $2.49M | Hold |
17,550
| – | – | 1.19% | 29 |
|
|
2015
Q3 | $2.15M | Buy |
17,550
+800
| +5% | +$104K | 1.07% | 32 |
|
|
2015
Q2 | $2.17M | Sell |
16,750
-400
| -2% | -$52.1K | 0.98% | 31 |
|
|
2015
Q1 | $2.3M | Sell |
17,150
-100
| -0.6% | -$12.9K | 1.02% | 32 |
|
|
2014
Q4 | $2.16M | Hold |
17,250
| – | – | 0.96% | 34 |
|
|
2014
Q3 | $2.1M | Sell |
17,250
-150
| -0.9% | -$18.2K | 0.97% | 33 |
|
|
2014
Q2 | $2.05M | Sell |
17,400
-5,900
| -25% | -$694K | 0.96% | 38 |
|
|
2014
Q1 | $2.8M | Sell |
23,300
-5,250
| -18% | -$624K | 1.3% | 21 |
|
|
2013
Q4 | $3.18M | Hold |
28,550
| – | – | 1.47% | 15 |
|
|
2013
Q3 | $2.63M | Sell |
28,550
-9,600
| -25% | -$868K | 1.38% | 21 |
|
|
2013
Q2 | $3.23M | Buy |
+38,150
| New | +$3.18M | 1.77% | 8 |
|
Other funds holding TMO
Monetary Management Group's TMO Position: Q2 2026 in Review
Monetary Management Group reduced its Thermo Fisher Scientific (TMO) stake by 5.3% in Q2 2026, selling an estimated $48K and leaving 1,770 shares worth $887K. The position accounts for 0.18% of the portfolio, ranked #105.
Monetary Management Group first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.2M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Monetary Management Group held 1,770 shares of Thermo Fisher Scientific worth $887K as of Q2 2026.
- Monetary Management Group sold 100 Thermo Fisher Scientific shares in Q2 2026, an estimated $48K.
- Thermo Fisher Scientific made up 0.18% of Monetary Management Group's portfolio in Q2 2026, its #105 holding.
- Monetary Management Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Monetary Management Group's Thermo Fisher Scientific position peaked at $5.2M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Monetary Management Group's 13F filing for Q2 2026, filed 12 Aug 2026.